Wyszynski DF

ORCID: 0000-0001-6293-3429 · 1 paper in corpus

2026

Efficacy and safety of casirivimab/imdevimab (REGEN-COV) in pregnant individuals with COVID-19: Literature review and insights from the COVID-19 International Drug Pregnancy Registry.

Obstetric Medicine ·doi:10.1177/1753495x251343113

IntroductionCasirivimab/imdevimab (CAS/IMD) comprises two monoclonal antibodies that neutralize SARS-CoV-2. Pregnant individuals were excluded from initial trials, limiting safety data.MethodsThe COVID-19 International Drug Pregnancy Regist…